CD19 and Miyoshi myopathy: With the application of serial transplantation models and clonogenic in vitro assays, MM stem cells have been suggested to be part of a subset of CD38–CD19+CD27+ B-cell precursors that do not express the classic MM markers CD38 or CD138 (Matsui et al., 2008).